126 related articles for article (PubMed ID: 14210196)
21. [Melphalan pharmacokinetics during isolated limb regional perfusion in patients with skin melanoma and soft tissue sarcoma].
Gafton GI; Senchik KY; Petrov VG; V V Semiglazov ; N V Tatyanicheva ; V G Bespalov ; Semiletova YV; Gafton IG; Zinoviev GV; Kireeva GS
Vopr Onkol; 2015; 61(6):932-6. PubMed ID: 26995981
[TBL] [Abstract][Full Text] [Related]
22. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
[TBL] [Abstract][Full Text] [Related]
23. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
[TBL] [Abstract][Full Text] [Related]
24. [THE TREATMENT OF TUMORS OF THE EXTREMITIES WITH REGIONAL PERFUSION].
BOECKL O; HOLLETSCHEK H; KAISER P; TRISKA H
Klin Med Osterr Z Wiss Prakt Med; 1964 Aug; 19():334-8. PubMed ID: 14299761
[No Abstract] [Full Text] [Related]
25. Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
Kam PC; Thompson JF
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1039-45. PubMed ID: 20604735
[TBL] [Abstract][Full Text] [Related]
26. RESULTS OF REGIONAL CHEMOTHERAPY OF NEOPLASMS OF THE UPPER BODY BY TEMPORARY MID-TORSO VASCULAR OCCLUSION.
CLAPP P; TAYAO MS; MILLER DG; LAWRENCE W
Cancer; 1964 Aug; 17():1012-25. PubMed ID: 14202589
[No Abstract] [Full Text] [Related]
27. Isolated limb infusion with hyperthermia and chemotherapy for advanced limb malignancy: factors influencing toxicity.
Duprat Neto JP; Mauro AC; Molina AS; Nishinari K; Zurstrassen CE; Costa OF; Belfort FA; Facure L; Fregnani JH
ANZ J Surg; 2014 Sep; 84(9):677-82. PubMed ID: 22998400
[TBL] [Abstract][Full Text] [Related]
28. [Regional chemotherapy--perfusion of the extremities].
Meyer T; Göhl J
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
[TBL] [Abstract][Full Text] [Related]
29. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM
Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234
[TBL] [Abstract][Full Text] [Related]
30. KAPOSI'S SARCOMA IN TANGANYIKA (TANZANIA).
JOHNSTONE G
J Trop Med Hyg; 1965 Jan; 68():1-8. PubMed ID: 14259525
[No Abstract] [Full Text] [Related]
31. Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma.
Smith HG; Cartwright J; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S356-61. PubMed ID: 26350373
[TBL] [Abstract][Full Text] [Related]
32. [STUDIES ON THE THERAPEUTIC USE OF SHORT-LIVED RADIOISOTOPES BY REGIONAL PERFUSION. EXPERIMENTAL RESEARCH WITH DY-165].
BIAGINI C; FICARI A; BRUZZESE E; CENTICOLELLA A; GRECO G
Minerva Nucl; 1964; 8():180-6. PubMed ID: 14175032
[No Abstract] [Full Text] [Related]
33. [Value of isolation-perfusion of the limbs in melanomas and sarcomas].
Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Kroon B
Ann Chir; 1995; 49(1):9-12. PubMed ID: 7741477
[No Abstract] [Full Text] [Related]
34. [OUR EXPERIENCE WITH INTRA-ARTERIAL CHEMOTHERAPY].
ROMIEU C; GARY-BOBO J; ROLET JF; PUJOL H
Bull Assoc Fr Etud Cancer; 1964; 51():325-8. PubMed ID: 14282897
[No Abstract] [Full Text] [Related]
35. [PRINCIPLES AND PROBLEMS OF REGIONAL TUMOR THERAPY].
MAGDON E; BACIGALUPO G; GUMMEL H
Dtsch Gesundheitsw; 1964 Jul; 19():1381-4 CONTD. PubMed ID: 14245918
[No Abstract] [Full Text] [Related]
36. Perfusion of melanoma. 105 isolated perfusions in 92 patients.
Golomb FM
Oncology; 1972; 26(2):197-205. PubMed ID: 4626136
[No Abstract] [Full Text] [Related]
37. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Cancer; 2009 May; 115(9):1932-40. PubMed ID: 19288571
[TBL] [Abstract][Full Text] [Related]
38. ISOLATION PERFUSION AS AN ADJUNCTIVE TREATMENT FOR MELANOMA OF THE EXTREMITIES.
CHRISTLIEB II; ALRICH EM
Va Med Mon (1918); 1964 Feb; 91():57-60. PubMed ID: 14119132
[No Abstract] [Full Text] [Related]
39. Perfusion of melanoma. 133 isolated perfusions in 114 patients.
Golomb FM
Panminerva Med; 1976; 18(1-2):8-10. PubMed ID: 813172
[No Abstract] [Full Text] [Related]
40. [Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs].
Abu-Abid S; Gutman M; Lev D; Inbar M; Chaitchik S; Sorkine P; Rudick V; Meller I; Klausner JM
Harefuah; 1996 Oct; 131(7-8):227-32, 296, 295. PubMed ID: 8940515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
